The efficacy of all-oral shorter MDR-TB and pre-XDR TB treatment in Russia

The efficacy of all-oral shorter MDR-TB and pre-XDR TB treatment in Russia

INTRODUCTION: treatment success of patients with multidrug and pre-extensively drug-resistant tuberculosis (MDR and pre-XDR-TB) (12-24 months) is 51% in the Russia. AIM: to evaluate the efficacy of treatment with 9-month regimens in MDR and pre-XDR-TB patients. MATERIALS-METHODS: the efficacy of tre...

Full description

Bibliographic Details
Main Authors: Anna Abramchenko, Anastasja Gaida, Mariya Romanova, Galina Mozhokina, Anastasia Samoilova, Irina Vasilyeva
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
treatment,drug-resistant
tuberculosis
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524003254

Internet

http://www.sciencedirect.com/science/article/pii/S2213716524003254

Similar Items